Professor and Assistant Dean for Research Texas Tech University School of Medicine
Disclosure(s): No financial relationships to disclose
Session Description Current guidelines should reassure practitioners concerning safety and benefits of hormone replacement therapy for symptomatic menopausal women. Nevertheless, a large market of non-FDA-approved formulations have been promoted as safer or more effective than conventional products despite little or no evidence to support such claims. These claims will be evaluated from a safety and ethical perspective.
Disclosure(s):
Robert P. Kauffman, MD: No financial relationships to disclose
.jpg "Robert Kauffman (he/him/his) photo")